Stay updated on TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T01:50:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page presents the completed record for a Phase 2 study of nivolumab-based treatment in advanced melanoma and bladder cancer, including its study plan, eligibility criteria, outcome measures, locations, and linked protocol document.
    Difference
    56%
    Check dated 2026-11-11T00:59:05.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:12:29.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    An NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:43:34.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T22:49:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, making the trial record inaccessible; this blocks visibility of locations, investigators, and other essential details that the page normally presents to users.
    Difference
    19%
    Check dated 2026-09-22T22:59:26.000Z thumbnail image

Stay in the know with updates to TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.